Bain Capital acquires Vitabiotics, including India’s Meyer Organics

Bain Capital has acquired UK nutraceuticals company Vitabiotics, whose portfolio includes Pregnacare, Perfectil, Wellman, Wellwoman and Osteocare. The deal also covers India’s Meyer Organics, with investment planned for innovation, e-commerce, distribution, supply-chain resilience and international expansion.

— Source publishedFri, 24 Jul, 2026, 14:29 IST·First seen Fri, 24 Jul, 2026, 14:33 IST·Source Mint · Companies

What happened

Bain Capital will acquire UK nutraceutical company Vitabiotics, including Meyer Organics in India. The investor plans to support innovation, e-commerce,

Key facts

  • $900 million to $1 billion reported valuation
  • Founded in 1971

Why this matters

The acquisition underscores the strategic value of combining trusted nutraceutical IP with India-market exposure and operational investment levers rather than pursuing immediate integration changes.

What to watch

  • Appointment of a Bain-linked board, new chief executive or India commercial leadership.
  • Material increases in digital advertising, influencer partnerships, subscription offers or marketplace storefront investment.
  • New India-specific product launches, especially under Pregnacare, Perfectil, Wellwoman or Meyer Organics brands.
  • Distribution agreements with major pharmacy chains, quick-commerce platforms, hospital networks or modern-trade retailers.
  • Manufacturing, warehousing or supply agreements in India, the UK, Europe or the Gulf.
  • Price-pack architecture changes, including smaller trial packs, premium formulations and online-exclusive bundles.
  • Evidence of retailer shelf-space gains or rising promotional activity from competing supplement brands.
  • Increase spending on Amazon, Flipkart, Nykaa, pharmacy-marketplace and direct-to-consumer channels.
  • Expand Meyer Organics distribution beyond core urban pharmacy networks into modern trade, tier-two cities and quick-commerce.
  • Launch localized science-led products in women’s health, pregnancy, beauty-from-within, bone health and immunity.
  • Build regional manufacturing, sourcing or co-packing capacity to reduce import exposure and improve in-stock performance.
  • Pursue bolt-on acquisitions or commercial partnerships in consumer health, diagnostics, digital wellness or pharmacy distribution.
  • Refresh international go-to-market strategy for Vitabiotics brands in the Middle East, Asia and other distributor-led markets.

Also reported by